If you have placed a bet in the recent IPO of Q-Line Biotech, then your bag can be filled with happiness on the day of listing. The upper price band of this company’s shares has been fixed at Rs 343, but recent data from Gray Market (GMP) shows that investors can make huge profits of up to Rs 43,200 in one go. This IPO was such a hit in the market that it was subscribed more than 102 times. Now all eyes are on the listing to be held on May 29.
What is the meaning of 102 times bumper subscription?
With the opening of the IPO of Q-Line Biotech, it became the first choice of retail investors as well as big institutions. This issue, which lasted for three days, received a better response from the market than expected. According to National Stock Exchange data, this issue has been subscribed a total of 102.42 times. This huge demand simply means that investors have full confidence in the future of the company. The company has raised capital of about Rs 214.48 crore through this IPO. The most important thing is that it was a completely fresh issue. This means that the promoters have not sold their stake, rather the entire amount received from the IPO will be directly invested in expanding the company’s operations.
Gray market premium is indicating bumper earnings
At present, the eyes of market experts are continuously focused on Gray Market Premium (GMP). At present, shares of Q-Line Biotech are trading at a handsome premium of around Rs 108 in the gray market. If we consider the fixed price band of Rs 343 as the basis, then accordingly the listing of shares is likely to be up by about 31.5 percent. If we understand this directly in mathematics, then investors are expected to get a profit of Rs 43,200 on one lot. However, market experts always say that gray market figures are just an estimate. The real trend of the market is decided only by the trading on the day of listing.
Check your allotment status like this
After huge subscription, every investor wants to know whether he gets shares or not. Checking your allotment status is a very simple process. For this you will have to go directly to the official website of National Stock Exchange (NSE). Select the option ‘Equity & SME IPO bid details’ on the homepage of the website. After this select ‘QLINE’ from the list of companies. Then enter your PAN card number (PAN) or application number correctly and click on the submit button. Within a few seconds, your status will appear on the screen whether shares have been allotted to you or not.
What does Q-Line Biotech do?
Q-Line Biotech is a well-known company primarily in the diagnostic healthcare sector. It manufactures kits, reagents and many other important medical devices used in medical tests. Their products are used in critical medical segments like hematology, clinical chemistry, immunodiagnostics and molecular diagnostics. Considering the increasing demand in the healthcare sector, the foundation of the company appears to be quite strong. The shares of investors who have received allotment will be listed on the NSE SME platform (Emerge) on Friday, May 29 at 10 am.
Disclaimer: This article is for information only and should not be considered as investment advice in any way. TV9 Bharatvarsha advises its readers and viewers to consult their financial advisors before taking any money-related decisions.
